NH2-terminal pentapeptide of endothelial interleukin 8 is responsible for the induction of apoptosis in leukemic cells and has an antitumor effect in vivo

Cancer Research

Volumn 59, Issue 22, 1999, Pages 5651-5655

  Terui, Yasuhito ^a   Tomizuka, Hiroshi ^a   Mishima, Yuji ^b   Ikeda, Masayuki ^b   Kasahara, Tadashi ^c   Uwai, Masaya ^a   Mori, Masaki ^a   Itoh, Takehito ^b   Tanaka, Miyuki ^b   Yamada, Muneo ^b   Shimamura, Seiichi ^b   Ishizaka, Yukihito ^d   Ozawa, Keiya ^a   Hatake, Kiyohiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b MORINAGA MILK INDUSTRY CO LTD   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; PENTAPEPTIDE; RECOMBINANT INTERLEUKIN 8; ALANYL VALYL LEUCYL PROLYL ARGININE; ALANYL-VALYL-LEUCYL-PROLYL-ARGININE; OLIGOPEPTIDE; PEPTIDE FRAGMENT;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; CELL CULTURE; CELL CYCLE; CELL STRAIN K 562; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; NICK END LABELING; NUDE MOUSE;

ANIMALS; APOPTOSIS; CELL CYCLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; IN SITU NICK-END LABELING; INTERLEUKIN-8; K562 CELLS; MICE; MICE, NUDE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; TUMOR CELLS, CULTURED;

EID: 0033570374     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell, 78: 539-542, 1994.
2. Terui, Y., Ikeda, M., Tomizuka, H., Kasahara, T., Ohtsuki, T., Uwai, M., Mori, M., Itoh, T., Tanaka, M., Yamada, M., Shimamura, S., Miura, Y., and Hatake, K. Identification of a novel apoptosis-inducing factor derived from leukemic cells: endothelial interleukin-8, but not monocyte-derived, induces apoplosis in leukemic cells. Biochem. Biophys. Res. Commun., 243: 407-411, 1998.
3. Terui, Y., Ikeda, M., Tomizuka, H., Kasahara, T., Ohtsuki, T., Uwai, M., Mori, M., Itoh, T., Tanaka, M., Yamada, M., Shimamura, S., Ozawa, K., and Hatake, K. Activated endothelial cells induces apoptosis in leukemic cells by endothelial interleukin-8. Blood, 92: 2672-2680, 1998.
4. Guigon, M., and Bonnet, D. Inhibitory peptides in hematopoiesis. Exp. Hematol., 23: 477-481, 1995.
5. Paukovits, W. R., Paukovits, J. B., Moser, M. H., Konstantinov, S., and Schulte-Hermann, R. Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation. Exp. Hematol., 26: 851-858, 1998.
6. Parker, A. N., and Pragnell, I. B. Inhibitors of haemopoiesis and their potential clinical relevance. Blood Rev., 9: 226-233, 1995.
7. Lozzio, C. B., and Lozzio, B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood, 45: 321-334, 1975.
8. Terui, Y., Furukawa, Y., Kikuchi, J., and Saito, M. Apoptosis during HL-60 cell differentiation is closely related to a G0/G1 cell cycle arrest. J. Cell. Physiol., 164: 74-84, 1995.
9. Williams, G. T. Programmed cell death: apoptosis and oncogenesis. Cell, 65: 1097-1098, 1991.
10. Kyriazis, A. P., Kyriazis, A. A., Scarpelli, D. G., Fogh, J., Rao, M. S., and Lepera, R. Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse: morphologic, biologic, and biochemical characteristics. Am. J. Pathol., 106: 250-260, 1982.
11. Walz, A., Peveri, P., Aschauer, H., and Baggiolini, M. Purification and amino acid sequence of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem. Biophys. Res. Commun., 149: 755-761, 1987.
12. Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., and Leonard, E. J. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA, 84: 9233-9237, 1987.
13. Schmid, J., and Weissmann, C. Induction of mRNA for a serine protease and a β-thromboglobulin-like protein in mitogen-stimulated human leukocytes. J. Immunol., 139: 250-256, 1987.
14. Yoshimura, T., Robinson, E. A., Appella, E., Matsushima, K., Showalter, S. D., Skeel, A., and Leonard, E. J. Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence. Mol. Immunol., 26: 87-93, 1989.
15. Lindley, I., Aschauer, H., Seifert, J. M., Lam, C., Brunowsky, W., Kownatzki, E., Thelen, M., Peveri, P., Dewald, B., von Tscharner, V., Walz, A., and Baggiolini, M. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc. Natl. Acad. Sci. USA, 85: 9199-9203, 1988.
16. Van Damme, J., Van Beeumen, J., Conings, R., Decock, B., and Billiau, A. Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of β-thromboglobulin. Eur. J. Biochem., 181: 337-344, 1989.
17. Gimbrone, M. A., Jr., Obin, M. S., Brock, A. F., Luis, E. A., Hass, P. E., Jert, C. A., Yip, Y. K., Leung, D. W., Lowe, D. G., Kohr, W. J., Darbonne, W. C., Bechtol, K. B., and Baker, J. B. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science (Washington DC), 246: 1601-1603, 1989.
18. Schrer, J-M., Sticherling, M., Henneicke, H. H., Preissner, W. C., and Christophers, E. IL-1α or tumor necrosis factor-α stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J. Immunol., 144: 2223-2232, 1990.
19. Leavell, K. J., Peterson, M. W., and Gross, T. J. Human neutrophil elastase abolishes interleukin-8 chemotactic activity. J. Leukocyte Biol., 61: 361-366, 1997.
20. Hollt, V. Opioid peptide processing and receptor selectivity. Annu. Rev. Pharmacol. Toxicol., 26: 59-77, 1986.
21. Plotnikoff, N. P., Faith, R. E., Murgo, A. J., Herberman, R. B., and Good, R. A. Methionine enkephalin: a new cytokine-human studies. Clin. Immunol. Immunopathol., 82: 93-101, 1997.
22. Laerum, O. D., and Paukovits, W. R. Inhibitory effects of a synthetic pentapeptide on hematopoietic stem cells in vitro and in vivo. Exp. Hematol., 12: 7-17, 1984.
23. Lenfant, M., Wdzieczak-Bakala, J., Guittet, E., Prome, J., Sotty, D., and Frindel, E. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc. Natl. Acad. Sci. USA, 86: 779-782, 1989.
24. Geng, Y-J., Hellstrand, K., Wennmalm, A., and Hansson, G. K. Apoptotic death of human leukemic cells induced by vascular expressing nitric oxide synthesis in response to γ-interferon and tumor necrosis factor-α. Cancer Res., 56: 866-874, 1996.
25. Folkman, J., and Ingber, D. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
26. Thorgeirsson, U. P., Lindsay, C. K., Cottam, D. W., and Gomez, D. E. Tumor invasion, proteolysis, and angiogenesis. J. Neurooncol., 18: 89-103, 1993.
27. Mantovani, A., Bussolino, F., and Introna, M. Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol. Today, 18; 231-240, 1997.
28. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin. An endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
29. Dong, Z., Kumar, R., Yang, X., and Fidler, I. J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell, 88: 801-810, 1997.
30. Baggiolini, M., Dewald, B., and Moser, B. Interleukin-8 and related chemokines-CXC and CC chemokines. Adv. Immunol., 55: 97-179, 1993.